Beijing LabTech Instruments (688056.SH) has announced a forecasted increase, with an estimated net profit of 40 to 43 million yuan in 2024, an increase of 45.12% to 56.01% year-on-year.
Lebertech (688056.SH) announced that the company is expected to achieve attributable to the parent company in 2024...
Beijing LabTech Instruments (688056.SH) announced that the company is expected to achieve a net profit attributable to the owners of the parent company of 40 to 43 million yuan in the year 2024. Compared with the same period last year (legally disclosed data), this represents an increase of 12.4375 million to 15.4375 million yuan, an increase of 45.12% to 56.01% year-on-year.
Related Articles

ANTENGENE-B (06996) founders, CEO, chairman and other management increased their holdings.

CEOVU (00798) will distribute a final dividend of HK $0.0049 per share on October 30th.

HESAI-W(02525) issued a total of 785,400 rewards.
ANTENGENE-B (06996) founders, CEO, chairman and other management increased their holdings.

CEOVU (00798) will distribute a final dividend of HK $0.0049 per share on October 30th.

HESAI-W(02525) issued a total of 785,400 rewards.

RECOMMEND

Pace Of Public Fund Issuance Slows, Hong Kong Stocks Become A Primary Focus
24/03/2026

Jensen Huang In‑Depth Interview: Token Economy Surge, AI Computing’s Share Of GDP To Multiply One Hundredfold, NVIDIA’s $10 Trillion Valuation Inevitable
24/03/2026

Are U.S.‑Iran Talks Genuine? At Minimum, Wall Street Read A Clear Signal From Trump’s Five‑Minute Rally
24/03/2026


